Parallel Advisors
HCAT icon

Parallel Advisors’s Health Catalyst HCAT Stock Holding History

Parallel Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-135
Closed -$612 – 3613
2025
Q1 		$612 Sell
135
-96
-42% -$508 ﹤0.01% 3210
2024
Q4 		$1.63K Hold
231
– – ﹤0.01% 3021
2024
Q3 		$1.88K Hold
231
– – ﹤0.01% 2909
2024
Q2 		$1.48K Buy
+231
New +$1.48K ﹤0.01% 2879
2023
Q4 		– Sell
-452
Closed -$4.57K – 3385
2023
Q3 		$4.57K Sell
452
-14
-3% -$167 ﹤0.01% 2531
2023
Q2 		$5.83K Sell
466
-74
-14% -$881 ﹤0.01% 2378
2023
Q1 		$6.3K Buy
540
+30
+6% +$382 ﹤0.01% 2328
2022
Q4 		$5.42K Buy
510
+256
+101% +$2.47K ﹤0.01% 2298
2022
Q3 		$2K Buy
254
+57
+29% +$755 ﹤0.01% 2659
2022
Q2 		$3K Buy
+197
New +$3.36K ﹤0.01% 2450
2022
Q1 		– Sell
-72
Closed -$3K – 3084
2021
Q4 		$3K Sell
72
-34
-32% -$1.55K ﹤0.01% 2577
2021
Q3 		$5K Buy
+106
New +$5.78K ﹤0.01% 2349

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parallel Advisors's HCAT Position: Q2 2025 in Review

Parallel Advisors sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 135 shares — an estimated $612 sold.

Parallel Advisors first reported a position in HCAT in Q3 2021 and held it in 12 quarters. The position peaked at $6.3K in Q1 2023. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

  • Parallel Advisors reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
  • Parallel Advisors sold 135 Health Catalyst shares in Q2 2025, an estimated $612.
  • Parallel Advisors first reported a position in Health Catalyst in Q3 2021 and held it in 12 quarters.
  • Parallel Advisors's Health Catalyst position peaked at $6.3K in Q1 2023.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.